We’re Reversing Alzheimer’s with the PATHS Brain Optimization Program
Why We Focus on Alzheimer’s Disease
We focus on Alzheimer’s disease because it is such a far-reaching problem. One in nine Americans age 65 and older will develop Alzheimer’s disease, and 50 percent of people over the age of 80 have Alzheimer’s. To date, there is no definite cure. As a result, the fear of losing one’s memory is the number one concern of our aging population, and justifiably so. Alzheimer’s is the third leading cause of death in America. The pharmaceutical industry has been searching for the “silver bullet,” a single pill that can cure Alzheimer’s. However, Alzheimer’s is not a singular disease. In fact, researchers have found more than 36 sources that can lead to a person developing dementia. This is why there is not one single drug that has worked on Alzheimer’s disease.
Ongoing medical research shows that there is new hope for patients with mild cognitive decline and early Alzheimer’s disease. Changes in lifestyle health behaviors – food, exercise, sleep, stress management, learning and social connection – have been shown in randomized clinical trials to have more impact on disease outcomes than pharmaceuticals (the FINGER study). The prestigious Institute of Medicine and U.S. National Library of Medicine endorsed changes in these lifestyle behaviors in a recent review in June 2017. Addressing the root causes of early cognitive decline can be a comprehensive strategy to optimize overall health and bring hope for symptomatic patients.